Jupiter Life Line Hospitals Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹8,432 Cr
- P/E
- 44.11
- ROE
- 13.06%
- PEG
- 1.19
- Price to sales
- 5.41
- Debt to equity
- 0.38
- 52W high / low
- ₹1,595 / ₹240
- Sales growth (5Y)
- 25.27%
- EBITDA margin
- 22.09%
- Net profit margin
- 12.64%
- Promoter holding
- 40.91%
- Sales (last year)
- ₹1,558 Cr
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
Guidance scorecard · Q2 FY27 call
What Jupiter Life Line Hospitals Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
10–20%- Dombivli Hospital's patient footfall is gradually increasing month-on-month, ramping up as expected.
- Revenue growth for mature hospitals (Thane and Pune) expected mostly in line with inflationary price hikes; Pune may see slower growth as it approaches higher occupancy (~75%).
- Indore and Dombivli hospitals have room for faster revenue growth due to occupancy expansions.
- ARPOB (Average Revenue per Occupied Bed) growth driven by case mix improvement and pricing renegotiations; expected to grow higher than inflation initially for new units, later aligning with inflation.
- Overall growth expected around 13-16% for existing units, with Dombivli continuing its ramp-up.
2 more points from Jupiter Life Line Hospitals Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Jupiter Life Line Hospitals Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Capex for current and upcoming hospital projects is ongoing and detailed in the financial presentation; internal accruals and cash on hand are expected to cover the next few years of capex.
- Towards the end of the current capex cycle, some additional debt may be explored but will remain within a board-imposed ceiling of 3x EBITDA.
- Jupiter recently acquired a company to set up an IV fluids manufacturing unit as a backward integration for its pharmacy subsidiary, aiming for cost management and margin improvement.
- The IV fluids manufacturing plant involves a capex of around INR 35-40 crores including infrastructure.
2 more points from Jupiter Life Line Hospitals Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
PlannedSee what Jupiter Life Line Hospitals Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- Jupiter Life Line Hospitals has 3 upcoming projects currently on track as mentioned by the management.
- The company plans to complete these 3 projects within the next 5 years.
- Focus remains on expanding hospital presence primarily in Western India.
2 more points from Jupiter Life Line Hospitals Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Jupiter Life Line Hospitals Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingJupiter Life Line Hospitals Ltd announcements
All announcements →- Financial resultsMajor developmentJupiter Life Line Hospitals Ltd announces Q2 FY27 results, land acquisition, and new subsidiary
Financials of Jupiter Life Line Hospitals Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Jupiter Life Line Hospitals Ltd
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FIIs + | 3.96% | 4.17% | 6.06% | 8.84% | 10.04% | 10.04% | 9.77% | 9.06% | 8.48% | 8.48% | 9.37% | 9.13% |
| DIIs + | 13.92% | 14.16% | 13.85% | 13.46% | 15.75% | 15.64% | 15.82% | 16.97% | 17.44% | 17.01% | 16.51% | 19.13% |
| Public + | 41.19% | 40.76% | 39.18% | 36.79% | 33.31% | 33.43% | 33.51% | 33.08% | 33.17% | 33.60% | 33.20% | 30.85% |
| No. of Shareholders | 39,348 | 35,107 | 35,797 | 34,081 | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 | 33,194 | 33,255 |
Financials of Jupiter Life Line Hospitals Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 263 | 273 | 291 | 289 | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 | 456 |
| Expenses + | 202 | 211 | 228 | 223 | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 | 350 |
| Operating Profit | 61 | 62 | 63 | 65 | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 | 107 |
| OPM % | 23% | 23% | 22% | 23% | 23% | 23% | 24% | 22% | 23% | 23% | 23% | 19% | 23% |
| Other Income + | 3 | 8 | 10 | 7 | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 | 11 |
| Interest | 12 | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 | 14 |
| Depreciation | 11 | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 | 28 |
| Profit before tax | 41 | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 | 75 |
| Tax % | 19% | 25% | 27% | 26% | 26% | 22% | 28% | 29% | 23% | 25% | 26% | 26% | 25% |
| Net Profit + | 34 | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 | 56 |
| EPS in Rs | 1.03 | 1.33 | 1.37 | 1.36 | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 | 1.71 |
Financials of Jupiter Life Line Hospitals Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 463 | 486 | 733 | 893 | 1,073 | 1,302 | 1,500 | 1,621 |
| Expenses + | 379 | 419 | 580 | 691 | 831 | 999 | 1,156 | 1,262 |
| Operating Profit | 84 | 67 | 153 | 201 | 242 | 303 | 343 | 359 |
| OPM % | 18% | 14% | 21% | 23% | 23% | 23% | 23% | 22% |
| Other Income + | 0 | 4 | 4 | 8 | 22 | 25 | 37 | 35 |
| Interest | 26 | 39 | 44 | 42 | 26 | 11 | 33 | 43 |
| Depreciation | 26 | 31 | 36 | 39 | 42 | 57 | 88 | 100 |
| Profit before tax | 33 | 2 | 77 | 129 | 195 | 261 | 260 | 250 |
| Tax % | 10% | 248% | 34% | 43% | 10% | 26% | 25% | |
| Net Profit + | 30 | -2 | 51 | 73 | 177 | 194 | 194 | 187 |
| EPS in Rs | 1.17 | -0.09 | 2.01 | 2.58 | 5.39 | 5.89 | 5.92 | 5.68 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | 3% | 3% |
Financials of Jupiter Life Line Hospitals Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 | 66 |
| Reserves | 186 | 188 | 243 | 309 | 1,103 | 1,291 | 1,479 | 1,565 |
| Borrowings + | 272 | 426 | 495 | 469 | 0 | 393 | 584 | 669 |
| Other Liabilities + | 94 | 124 | 120 | 151 | 112 | 168 | 235 | 261 |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | 2,560 |
| Fixed Assets + | 435 | 630 | 684 | 720 | 718 | 978 | 1,384 | 1,439 |
| CWIP | 10 | 26 | 27 | 29 | 74 | 185 | 129 | 194 |
| Investments | 2 | 7 | 3 | 2 | 17 | 507 | 486 | 385 |
| Other Assets + | 156 | 126 | 195 | 235 | 473 | 247 | 364 | 543 |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | 2,560 |
Financials of Jupiter Life Line Hospitals Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 74 | 123 | 137 | 176 | 115 | 267 | 268 |
| Cash from Investing Activity + | -43 | -295 | -84 | -94 | -246 | -497 | -442 |
| Cash from Financing Activity + | -32 | 184 | 32 | -51 | 128 | 297 | 136 |
| Net Cash Flow | -1 | 12 | 85 | 31 | -3 | 66 | -38 |
| Free Cash Flow | 46 | -118 | 46 | 100 | 29 | -60 | -234 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 106% | 198% | 95% | 97% | 68% | 109% | 97% |
Financials of Jupiter Life Line Hospitals Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 16 | 14 | 19 | 19 | 12 | 18 |
| Inventory Days | 64 | 48 | 39 | 44 | 41 | 38 | 49 |
| Days Payable | 268 | 217 | 157 | 164 | 120 | 99 | 121 |
| Cash Conversion Cycle | -169 | -152 | -104 | -101 | -59 | -49 | -54 |
| Working Capital Days | 17 | -7 | -24 | -24 | -5 | -19 | -21 |
| ROCE % | 7% | 17% | 21% | 22% | 18% | 15% |
Guidance history
How Jupiter Life Line Hospitals Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Flat | Planned | Planned | — |
| Q4 FY26 call → | 10–20% | Flat | Planned | Planned | — |
| Q3 FY26 call → | 10–20% | Down 0–2% | Planned | — | — |
| Q2 FY26 call → | 10–20% | Down 0–2% | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
20 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −19.3% | 39% |
| Last 6 months | −3.6% | 50% |
| Last 3 months | −20.5% | 21% |
The price is 25.7% below its all-time high of ₹332.4 (30 Jul 2026). Stocks more than 20% below their peak have their score halved, so 39 became 20.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Jupiter Life Line Hospitals Ltd: 0.4 × 39 + 0.4 × 50 + 0.2 × 21 = 39, halved to 20 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 16 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Jupiter Life Line Hospitals Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio